ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,718Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 47

$446K Total Retail Price of All Prescriptions

Rank: 12 out of 47

320 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

14% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,964 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OXYCODONE HCL 901 289 S2 1 38
LISINOPRIL 595 437 2 2
SIMVASTATIN 406 345 3 1
OMEPRAZOLE 352 238 4 5
PRAVASTATIN SODIUM 345 238 5 14
LEVOTHYROXINE SODIUM 342 213 6 4
METFORMIN HCL 324 199 7 8
FUROSEMIDE 276 240 8 7
HYDROCHLOROTHIAZIDE 265 216 9 10
METOPROLOL SUCCINATE 257 218 10 20
METOPROLOL TARTRATE 230 162 11 6
RANITIDINE HCL 219 162 12 26
LOVASTATIN 198 134 13 33
AMLODIPINE BESYLATE 182 127 14 3
CITALOPRAM HBR 180 110 15 24
WARFARIN SODIUM 165 138 16 13
HYDROCODONE-ACETAMINOPHEN 160 133 S3 17 9
FLUTICASONE PROPIONATE 156 66 18 55
LOSARTAN POTASSIUM 144 115 19 37
ZOLPIDEM TARTRATE 134 52 20 16
ATORVASTATIN CALCIUM 109 48 21 11
FLUOXETINE HCL 105 44 22 76
POTASSIUM CHLORIDE 96 82 23 22
ALLOPURINOL 95 80 24 36
GABAPENTIN 92 36 25 15
FENTANYL 88 19 S2 26 88
OXYCODONE-ACETAMINOPHEN 86 65 S2 27 66
TAMSULOSIN HCL 82 80 28 30
FINASTERIDE 80 66 29 106
AZITHROMYCIN 79 48 30 47
CARVEDILOL 79 75 30 27
TRIAMTERENE-HCTZ 76 46 32 123
METHADONE HCL 73 0 S2 33 203
VENTOLIN HFA 69 11 34 43
CARISOPRODOL 67 0 R 35 210
ALENDRONATE SODIUM 65 61 36 32
PROAIR HFA 64 35 37 87
CLOPIDOGREL 63 55 38 29
GLIPIZIDE 62 56 39 78
BISOPROLOL-HYDROCHLOROTHIAZIDE 62 52 39 114
OXYCONTIN 60 30 S2 41 174
DIGOXIN 55 55 42 61
FLOVENT HFA 54 17 43 178
SERTRALINE HCL 53 49 44 28
CYCLOBENZAPRINE HCL 52 21 R 45 83
HYDROCORTISONE 51 34 46 171
ISOSORBIDE MONONITRATE ER 50 50 47 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.